EHI and KLAS Partner to Improve NHS IT Measures

Ehealth Insider (EHI) partnering with US research firm KLAS to provide a complete picture of the UK healthcare market

2013-01-30

LONDON, ENGLAND, January 30, 2013 (Press-News.org) EHI, www.ehi.co.uk the UK's preeminent independent health IT news, research, and events firm, announced today that it has formed a partnership with leading US health technology research firm KLAS Enterprises.

The new partnership between EHI and KLAS is designed to improve transparency and performance measures for the UK health technology market. The objective will be to ensure that healthcare providers and the patients they serve gain the maximum benefit from key investments such as electronic patient records and other clinical software and medical equipment.

Additionally, the partnership will focus on cross-promoting respective market intelligence services in the firms' respective home markets. EHI will cross-market KLAS reports in the UK, while KLAS will cross-market EHI research products and events to US-based suppliers working in the UK market.

EHI provides detailed market data on the UK health technology sector, focusing on pinpointing market opportunities and health provider performance.

KLAS Enterprises, LLC, is focused on a global mission to improve healthcare delivery by enabling providers to be heard and to be counted. Working with thousands of healthcare executives and clinicians around the world, KLAS gathers data on software, services, medical equipment, and infrastructure systems to deliver timely reports, trends, and statistical overviews.

Jon Hoeksma, co-founder of EHI, said, "The UK health IT market is undergoing huge change, but it lacks good, reliable performance measures, both on supplier performance and on how healthcare providers benefit from technology investments. The new partnership between EHI and KLAS will help advance the visibility of both and help NHS trusts make the most of their technology investments."

"This partnership allows us to further our global mission to improve healthcare through transparency in decisions," said Chris Brown, director of international research at KLAS. "Together with EHI, we can bring about positive change to healthcare, particularly in the UK."

EHI and KLAS will also explore opportunities for jointly authored and published reports that develop UK-specific performance metrics in health IT and translate US market dynamics for an NHS and wider UK health audience. Further opportunities for joint events will also be examined as part of this agreement.

Editor's Notes

EHI Intelligence
EHI Intelligence is the leading market intelligence service focused on the UK healthcare IT market. The banded subscription service provides verified pinpoint market intelligence information on the IT systems and clinical software installed across the UK NHS--including England, Scotland, Wales, and Northern Ireland. At the core of the service is the NHS Trust IT database, which includes a detailed profile of every UK NHS trust, including regulatory and financial performance measures. The service also comprises a range of user-tailored alerts, market analysis, and detailed reports. http://www.ehi.co.uk/ehi-intelligence/home.cfm

KLAS
KLAS is a research firm on a global mission to improve healthcare delivery by enabling providers to be heard and to be counted. Working with thousands of healthcare executives and clinicians, KLAS gathers data on software, services, medical equipment, and infrastructure systems to deliver timely reports, trends, and statistical overviews. The research directly represents the provider voice and acts as a catalyst for improving vendor performance. KLAS was founded in 1996, and their staff and advisory board average 25 years of healthcare information technology experience. For more information, go to www.KLASresearch.com, email marketing@KLASresearch.com, or call 1-800-920-4109 to speak with a KLAS representative. Follow KLAS on Twitter at www.twitter.com/KLASresearch.

EHI Live 2013 www.ehilive.co.uk
EHI Live 2013 is a two-day conference and exhibition recognized as the key event in the UK eHealth calendar. It is organized by the team behind the industry news service eHealth Insider. EHI Live brings together suppliers, healthcare IT professionals, and clinicians to discuss and debate the issues facing those involved in healthcare IT who want to use IT to improve the efficiency and quality of health services. EHI Live attracts delegates, visitors, and exhibitors from across the UK and internationally.

EHI Live 2013 will take place at the NEC, Birmingham on 5-6 November 2013.

For further information, contact
Charlie Beall, for EHI
Charlie@e-health-media.com
Tel: +44 (0)20 7785 6956
Mob: +44(0)7584 281649

ELSE PRESS RELEASES FROM THIS DATE:

OM Spirits Debuts in Northern California at Mollie Stones and SFO

2013-01-30

After a great launch success in the Southern California market, OM spirits heads North to bring their certified organic, sustainable ready-to-pour cocktails to the Bay area. Crafted by mixology consultant Natalie Bovis in 2012, the spirits use lush, exotic, and extraordinary ingredient combinations. Each designed with a brilliant flavor profile and an eye toward sustainability in home entertaining. Additionally, all of OM's packaging is eco-friendly. From the specially designed light-weight bottle to the labels that are printed at a wind-powered printing facility, with ...

Dr. Keith Ostrosky: Improved Oral Health Could Enhance Professional Success

2013-01-30

Smiling is something that all professionals are encouraged to do when interacting with others--particularly if they are directly communicating with clients, shareholders, and other important people who support the success of a business. As such, many people are not surprised to find a correlation between an improved smile and enhanced professional opportunities. In a reaction to an article posted by Deseret News, Dr. Keith Ostrosky, noted dental professional, explains that he has seen a major difference in the career prospects of several of his patients after they underwent ...

Intertops Sportsbook Offering Super Bowl Bettors $200 Free Bet -- $100 Super Bowl Bonus Available Now Till Kick Off

2013-01-30

The biggest single sports betting event of the year is just around the corner and Intertops, the world's first and still most trusted online sportsbook, is offering American football fans a $200 Super Bowl Free Bet and giving an up to $100 deposit bonus. Everyone wagering at least $1000 on Super Bowl XLVII (minimum odds: -200 / 1.5) up until kick off on February 3rd can claim a $200 free bet after the champion has been crowned. "Talk about a win-win situation," said an Intertops' sportsbook manager. "Win or lose, the Free Bet will be waiting!" San ...

RakeTheRake's iPad Mini Giveaway!

2013-01-30

RakeTheRake, the world's leading rakeback provider, are once again providing their players with the chance to win brand new iPad Minis - this time in a series of nine February freerolls running across WPT and Party Poker, with one iPad to be won in every freeroll. All real-money RakeTheRake players with either a WPT Poker or Party Poker rakeback account are eligible to register for the tournaments. The freerolls will run across WPT and Party at 20:00 GMT (15:00 EST, 20:00 CET) on the following days: - Saturday 2nd February - Monday 4th February - Wednesday 6th February - ...

Darrin Sherrill Celebrates Commercial Pilot Certification

2013-01-30

Darrin Sherrill is proud to announce and celebrate his Commercial Pilot certification. Having been a recreational pilot for many years, becoming a certified Multi-Engine Land Commercial Pilot is a milestone in Darrin Sherrill's life. With over 675 hours of flight time, Darrin Sherrill loves the air and is thrilled to improve his skills and expand his aviation opportunities. The commercial pilot license allows Darrin Sherrill to fly passengers and receive compensation for his services. The standards that Darrin Sherrill exceeded to obtain the certification are in line ...

Indie Developer One Little Goat Pleads with Apple CEO - Stop Rejecting My App

2013-01-30

One Little Goat proprietor Philip Lemon, believes his app was rejected solely because one of the eight celebrity caricatures in the game is based on the late Steve Jobs. He supports his claim by providing the following correspondence from Apple; "We've reviewed your app and determined that we cannot post your application because it appears to contain features, namely, imagery, that bear a resemblance to several well-known third-party marks, including Steve Jobs." Phil's response to this was, "Well Duh, it's a parody. Do a search and you'll find dozens, ...

Toronto Podiatrist Offers Improved Treatment of Plantar Fasciitis

2013-01-30

Many people spend the majority of their days on their feet and pain may often interfere with their daily activities. If a patient experiences heel pain or discomfort, it is important to begin treatment immediately. Sheldon Nadal, D.P.M., Toronto podiatrist, is the excellent source for treating and protecting patients' heels from further damage. Plantar fasciitis is an inflammation of the band of tissue (the fascia) that extends from the heel to the toes. The fascia first becomes irritated followed by inflammation, which causes heel pain or arch pain. One of the most ...

Severna Park Dentist Offer New Patient Services On Practice Website

2013-01-30

Dr. Amanda McPherson, dentist from Severna Park, is excited to be offering a detailed new patient page on her practice's comprehensive dental website. The new patient material is designed to make it simple for patients to locate and learn about Dr. McPherson's practice. "I am glad that our practice is providing new patient services on our website. I believe we offer a great level of service at our practice and that any new patients will quickly become regular patients. I look forward to treating any patients that decide to schedule an appointment with us for the ...

Cash Train's Scheduled for an Unstoppable Service

2013-01-30

Cash Train, one of the most well-known names in Australian short term lending, has seen demand for its payday loans double in recent months. This has been partly due to the success of their TV advertising campaign as well as other factors, as Tim Dean, Founder of Cash Train explains: "The TV advert has been a huge success for us, and as a result we have been able to expand our support team to meet the increasing demand. The success of Cash Train is not just due to our advertising but also our dedication to meeting our customer's needs. This means getting the cash ...

Barclays Mobile Banking App Now Has 1 Million Registered Users

2013-01-30

The Barclays Mobile Banking app was launched in July 2012 and was downloaded by more than a million customers before the end of the year. It's an impressive achievement, which reflects the ever-increasing demand for Mobile Banking. The app gives users secure access to Online Banking wherever and whenever they want. They can check their balances, view recent transactions, transfer money between Barclays accounts and find their nearest Barclays branch or ATM. What's more, the Barclays Mobile Banking app keeps getting better. It now comes with Mobile PINsentry - a ...

LAST 30 PRESS RELEASES:

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC